Estimating antimicrobial resistance burden in Europe-what are the next steps?

Lancet Public Health. 2022 Nov;7(11):e886-e887. doi: 10.1016/S2468-2667(22)00250-X. Epub 2022 Oct 14.

Authors

Nasreen Hassoun-Kheir¹, Stephan Harbarth²

Affiliations

¹ Infection Control Program, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva Switzerland.
² Infection Control Program, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva Switzerland. Electronic address: stha@hcuge.ch.

PMID: 36244349
DOI: 10.1016/S2468-2667(22)00250-X

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial*
Europe / epidemiology
Humans

Substances

Anti-Bacterial Agents